Providence First Trust’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9,053
| Closed | -$1.24M | – | 99 |
|
|
2024
Q1 | $1.24M | Sell |
9,053
-500
| -5% | -$68.6K | 0.54% | 52 |
|
|
2023
Q4 | $1.3M | Sell |
9,553
-87
| -0.9% | -$11.8K | 0.64% | 45 |
|
|
2023
Q3 | $1.18M | Sell |
9,640
-3,874
| -29% | -$474K | 0.66% | 44 |
|
|
2023
Q2 | $1.72M | Sell |
13,514
-2,011
| -13% | -$255K | 0.94% | 39 |
|
|
2023
Q1 | $2.01M | Sell |
15,525
-178
| -1% | -$23K | 1.15% | 31 |
|
|
2022
Q4 | $2.06M | Hold |
15,703
| – | – | 1.21% | 30 |
|
|
2022
Q3 | $1.84M | Sell |
15,703
-1,015
| -6% | -$119K | 1.12% | 35 |
|
|
2022
Q2 | $1.97M | Hold |
16,718
| – | – | 1.11% | 35 |
|
|
2022
Q1 | $2.18M | Hold |
16,718
| – | – | 1.04% | 36 |
|
|
2021
Q4 | $2.55M | Hold |
16,718
| – | – | 1.15% | 32 |
|
|
2021
Q3 | $2.7M | Hold |
16,718
| – | – | 1.28% | 30 |
|
|
2021
Q2 | $2.74M | Hold |
16,718
| – | – | 1.29% | 33 |
|
|
2021
Q1 | $2.52M | Buy |
+16,718
| New | +$2.52M | 1.24% | 31 |
|